↓ Skip to main content

A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood

Overview of attention for article published in Journal of Translational Medicine, May 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
2 X users
patent
1 patent
googleplus
1 Google+ user

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood
Published in
Journal of Translational Medicine, May 2014
DOI 10.1186/1479-5876-12-143
Pubmed ID
Authors

Masaru Watanabe, Masakuni Serizawa, Takeshi Sawada, Kazuo Takeda, Toshiaki Takahashi, Nobuyuki Yamamoto, Fumiaki Koizumi, Yasuhiro Koh

Abstract

Personalized cancer treatment relies on the accurate detection of actionable genomic aberrations in tumor cells. Circulating tumor cells (CTCs) could provide an alternative genetic resource for diagnosis; however, the technical difficulties in isolating and analyzing rare CTCs have limited progress to date. In this preclinical study, we aimed to develop an improved capture system for molecular characterization of CTCs based on a novel cell sorting technology.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 2%
France 1 2%
Unknown 57 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 24%
Researcher 14 24%
Student > Master 8 14%
Student > Bachelor 5 8%
Student > Doctoral Student 3 5%
Other 7 12%
Unknown 8 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 31%
Medicine and Dentistry 12 20%
Engineering 7 12%
Biochemistry, Genetics and Molecular Biology 5 8%
Chemistry 2 3%
Other 0 0%
Unknown 15 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2016.
All research outputs
#6,030,127
of 22,756,196 outputs
Outputs from Journal of Translational Medicine
#902
of 3,978 outputs
Outputs of similar age
#57,174
of 226,329 outputs
Outputs of similar age from Journal of Translational Medicine
#10
of 68 outputs
Altmetric has tracked 22,756,196 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,329 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.